Risk stratification for therapeutic management and prognosis.

Otavio R Coelho-Filho, Leelakrishna Nallamshetty, Raymond Y Kwong

Journal: Heart failure clinics 2009;5(3):437-55, vii

PMID: 19564018

Full Text on Elsevier Science View on PubMed

Abstract

In coronary artery disease (CAD), cardiac magnetic resonance (CMR) imaging can integrate several types of pulse-sequence examinations (eg, myocardial perfusion, cine wall motion, T2-weighted imaging for myocardial edema, late gadolinium enhancement, and CMR angiography) that can provide anatomic, functional, and physiologic information about the heart in a single imaging session. Because of this ability to interrogate myocardial physiology using different pulse sequence techniques within a single CMR session, this technique has been recognized increasingly in many centers as the test of choice for assessing patients who present with cardiomyopathy of undetermined cause. This article first reviews the current evidence supporting the prognosticating role of CMR in assessing CAD and then discusses CMR applications and prognostication in many non-coronary cardiac conditions.

Address: Brigham and Women's Hospital, Boston, MA 02115, USA.

DOI: 10.1016/j.hfc.2009.02.010

Link outs

Free resources

Medical:

https://medlineplus.gov/coronaryarterydisease.html

Miscellaneous:

https://assays.cancer.gov/CPTAC-323

Subscription / membership required

Full Text Sources:

MeSH Terms: Amyloidosis, Cardiomyopathies, Chagas Cardiomyopathy, Coronary Artery Disease, Endomyocardial Fibrosis, Fabry Disease, Humans, Iron Overload, Magnetic Resonance Imaging, Magnetic Resonance Imaging, Cine, Myocardial Ischemia, Myocardial Perfusion Imaging, Myocarditis, Prognosis, Risk Assessment, Sarcoidosis